The role of neuroimaging in the diagnosis of vascular dementia
G. W. Small,
G. W. Small
UCLA Neuropsychiatric Institute, Los Angeles, CA, USA
Search for more papers by this authorG. W. Small,
G. W. Small
UCLA Neuropsychiatric Institute, Los Angeles, CA, USA
Search for more papers by this authorGary W. Small, M.D., Parlow-Solomon Professor on Aging, Professor of Psychiatry and Biobehavioral Sciences, UCLA Neuropsychiatric Institute, 88–201, 760 Westwood Plaza, Los Angeles, CA 90024, USA
Tel.: +1 310 825 0291
Fax: +1 310 825 3910
e-mail: [email protected]
Abstract
Vascular dementia (VaD) and Alzheimer's disease share many pathological and clinical characteristics. Whereas clinical criteria can help differentiate VaD from other types of dementia, neuroimaging is required for confirmation of vascular lesions. Neuroimaging also provides information about location and size of vascular lesions that can lead to a better understanding of symptoms and may help guide therapy.
References
- 1 Pohjasvaara T, Mantyla R, Salonen O et al. How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia. Arch Neurol 2000; 57: 1295–300.
- 2 Leys D, Erkinjuntti T, Desmond DW et al. Vascular dementia: the role of cerebral infarcts. Alzheimer Dis Assoc Disord 1999; 13(Suppl. 3): S38–48.
- 3 Erkinjuntti T, Bowler JV, Decarli CS et al. Imaging of static brain lesions in vascular dementia: implications for clinical trials. Alzheimer Dis Assoc Disord 1999; 13(Suppl. 3): S81–90.
- 4 Erkinjuntti T. Clinical deficits of Alzheimer's disease with cerebrovascular disease and probable VaD. Int J Clin Pract Suppl 2001; 120(Suppl.): 14–23.
- 5 Erkinjuntti T. Types of multi-infarct dementia. Acta Neurol Scand 1987; 75: 391–9.
- 6 Erkinjuntti T, Haltia M, Palo J, Sulkava R, Paetau A. Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study. J Neurol Neurosurg Psychiatry 1988; 51: 1037–44.
- 7 Erkinjuntti T, Hachinski VC. Rethinking vascular dementia. Cerebrovasc Dis 1993; 3: 3–23.
- 8 Tatemichi TK. How acute brain failure becomes chronic. a view of the mechanisms of dementia related to stroke. Neurology 1990; 40: 1652–9.
- 9 Erkinjuntti T, Inzitari D, Pantoni L et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl 2000; 59: 23–30.
- 10 Roman GC. Binswanger disease: the history of a silent epidemic. Ann NY Acad Sci 2000; 903: 19–23.
- 11 Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol 1993; 50: 873–80.
- 12 Groves WC, Brandt J, Steinberg M et al. Vascular dementia and Alzheimer's disease: is there a difference? A comparison of symptoms by disease duration. J Neuropsychiatry Clin Neurosci 2000; 12: 305–15.
- 13 Fischer P, Gatterer G, Marterer A, Simanyi M, Danielczyk W. Course characteristics in the differentiation of dementia of the Alzheimer type and multi-infarct dementia. Acta Psychiatr Scand 1990; 81: 551–3.
- 14 Skoog I. Blood pressure and dementia. In: L Hansson, WH Birkenhager, eds. Handbook of hypertension: assessment of hypertensive organ damage, vol. 18. Amsterdam: Elsevier Science BV, 1997; 303–31.
- 15 Kalaria RN, Ballard C. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord 1999; 13(Suppl. 3): S115–23.
- 16 Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. JAMA 1997; 277: 813–7.
- 17 Pasquier F, Leys D, Scheltens P. The influence of coincidental vascular pathology on symptomatology and course of Alzheimer's disease. J Neural Transm Suppl 1998; 54: 117–27.
- 18 Togashi H, Matsumoto M, Yoshioka M, Hirokami M, Minami M, Saito H. Neurochemical profiles in cerebrospinal fluid of stroke-prone spontaneously hypertensive rats. Neurosci Lett 1994; 166: 117–20.
- 19 Tohgi H, Abe T, Kimura M, Saheki M, Takahashi S. Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia. J Neural Transm 1996; 103: 1211–20.
- 20 Gottfries CG, Blennow K, Karlsson I, Wallin A. The neurochemistry of vascular dementia. Dementia 1994; 5: 163–7.
- 21 Gattu M, Pauly JR, Boss KL, Summers JB, Buccafusco JJ. Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. I. Brain Res 1997; 771: 89–103.
- 22 Saito H, Togashi H, Yoshioka M, Nakamura N, Minami M, Parvez H. Animal models of vascular dementia with emphasis on stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol Suppl 1995; 1: S257–9.
- 23 Roman GC, Tatemichi TK, Erkinjuntti T et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS–AIREN International Workshop. Neurology 1993; 43: 250–60.
- 24 Moroney JT, Bagiella E, Desmond DW et al. Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology 1997; 49: 1096–105.
- 25 Rockwood K, MacKnight C, Wentzel C et al. The diagnosis of ‘mixed’ dementia in the Consortium for the Investigation of Vascular Impairment of Cognition (CIVIC). Ann NY Acad Sci 2000; 903: 522–8.
- 26 Jagust WJ, Haan MN, Reed BR, Eberling JL. Brain perfusion imaging predicts survival in Alzheimer's disease. Neurology 1998; 51: 1009–13.
- 27 Silverman DHS, Small GW, Chang CY et al. Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term clinical outcome. JAMA 2001; 286: 2120–7.
- 28 Arai H, Terajima M, Miura M et al. Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease. Ann Neurol 1995; 38: 649–52.
- 29 Motter R, Vigo-Pelfrey C, Kholodenko D et al. Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol 1995; 38: 643–8.
